{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:49:11Z","timestamp":1788544151290,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,5,30]],"date-time":"2010-05-30T00:00:00Z","timestamp":1275177600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s10048-010-0248-3","type":"journal-article","created":{"date-parts":[[2010,5,29]],"date-time":"2010-05-29T09:44:37Z","timestamp":1275126277000},"page":"435-439","source":"Crossref","is-referenced-by-count":44,"title":["Age at onset in Huntington\u2019s disease: replication study on the associations of ADORA2A, HAP1 and OGG1"],"prefix":"10.1007","volume":"11","author":[{"given":"Elahe","family":"Taherzadeh-Fard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Saft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Wieczorek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg T.","family":"Epplen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Arning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,30]]},"reference":[{"key":"248_CR1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/gm80","volume":"1","author":"JF Gusella","year":"2009","unstructured":"Gusella JF, Macdonald ME (2009) Huntington's disease: the case for genetic modifiers. Genome Med 1:80","journal-title":"Genome Med"},{"key":"248_CR2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10048-004-0198-8","volume":"6","author":"L Arning","year":"2005","unstructured":"Arning L, Kraus PH, Valentin S, Saft C, Andrich J, Epplen JT (2005) NR2A and NR2B receptor gene variations modify age at onset in Huntington disease. Neurogenetics 6:25\u201328","journal-title":"Neurogenetics"},{"key":"248_CR3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/jmg.2006.045153","volume":"44","author":"JM Andresen","year":"2007","unstructured":"Andresen JM, Gay\u00e1n J, Cherny SS, Brocklebank D, Alkorta-Aranburu G, Addis EA, US-Venezuela Collaborative Research Group, Cardon LR, Housman DE, Wexler NS (2007) Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds. J Med Genet 44:44\u201350","journal-title":"J Med Genet"},{"key":"248_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1326-4-3","volume":"4","author":"P Weydt","year":"2009","unstructured":"Weydt P, Soyal SM, Gellera C, Didonato S, Weidinger C, Oberkofler H, Landwehrmeyer GB, Patsch W (2009) The gene coding for PGC-1alpha modifies age at onset in Huntington's disease. Mol Neurodegener 4:3","journal-title":"Mol Neurodegener"},{"key":"248_CR5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-1326-4-10","volume":"4","author":"E Taherzadeh-Fard","year":"2009","unstructured":"Taherzadeh-Fard E, Saft C, Andrich J, Wieczorek S, Arning L (2009) PGC-1alpha as modifier of onset age in Huntington disease. Mol Neurodegener 4:10","journal-title":"Mol Neurodegener"},{"key":"248_CR6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.nbd.2009.06.009","volume":"35","author":"CM Dhaenens","year":"2009","unstructured":"Dhaenens CM, Burnouf S, Simonin C, Van Brussel E, Duhamel A, Defebvre L, Duru C, Vuillaume I, Cazeneuve C, Charles P, Maison P, Debruxelles S, Verny C, Gervais H, Azulay JP, Tranchant C, Bachoud-Levi AC, D\u00fcrr A, Bu\u00e9e L, Krystkowiak P, Sablonni\u00e8re B, Blum D, Huntington French Speaking Network (2009) A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease. Neurobiol Dis 35:474\u2013476","journal-title":"Neurobiol Dis"},{"key":"248_CR7","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/hmg\/ddn003","volume":"17","author":"S Metzger","year":"2008","unstructured":"Metzger S, Rong J, Nguyen HP, Cape A, Tomiuk J, Soehn AS, Propping P, Freudenberg-Hua Y, Freudenberg J, Tong L, Li SH, Li XJ, Riess O (2008) Huntingtin- associated protein-1 is a modifier of the age-at-onset of Huntington's disease. Hum Mol Genet 17:1137\u20131146","journal-title":"Hum Mol Genet"},{"key":"248_CR8","author":"F Copped\u00e8","year":"2009","unstructured":"Copped\u00e8 F, Migheli F, Ceravolo R, Bregant E, Rocchi A, Petrozzi L, Unti E, Lonigro R, Siciliano G, Migliore L (2009) The hOGG1 Ser326Cys polymorphism and Huntington's disease. Toxicology. doi: 10.1016\/j.tox.2009.10.019","journal-title":"Toxicology"},{"key":"248_CR9","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/378398a0","volume":"378","author":"XJ Li","year":"1995","unstructured":"Li XJ, Li SH, Sharp AH, Nucifora FC Jr, Schilling G, Lanahan A, Worley P, Snyder SH, Ross CA (1995) A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378:398\u2013402","journal-title":"Nature"},{"key":"248_CR10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4161\/cam.3.1.7511","volume":"3","author":"LL Wu","year":"2009","unstructured":"Wu LL, Zhou XF (2009) Huntingtin associated protein 1 and its functions. Cell Adh Migr 3:71\u201376","journal-title":"Cell Adh Migr"},{"key":"248_CR11","doi-asserted-by":"crossref","first-page":"19220","DOI":"10.1074\/jbc.273.30.19220","volume":"273","author":"SH Li","year":"1998","unstructured":"Li SH, Hosseini SH, Gutekunst CA, Hersch SM, Ferrante RJ, Li XJ (1998) A human HAP1 homologue. Cloning, expression, and interaction with huntingtin. J Biol Chem 273:19220\u201319227","journal-title":"J Biol Chem"},{"key":"248_CR12","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1074\/jbc.M109.073197","volume":"285","author":"LL Wu","year":"2010","unstructured":"Wu LL, Fan Y, Li S, Li XJ, Zhou XF (2010) Huntingtin-associated protein-1 interacts with pro-brain-derived neurotrophic factor and mediates its transport and release. J Biol Chem 285:5614\u20135623","journal-title":"J Biol Chem"},{"key":"248_CR13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature05778","volume":"447","author":"IV Kovtun","year":"2007","unstructured":"Kovtun IV, Liu Y, Bjoras M, Klungland A, Wilson SH, McMurray CT (2007) OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature 447:447\u2013452","journal-title":"Nature"},{"key":"248_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/abbi.2000.1773","volume":"377","author":"S Boiteux","year":"2000","unstructured":"Boiteux S, Radicella JP (2000) The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. Arch Biochem Biophys 377:1\u20138","journal-title":"Arch Biochem Biophys"},{"key":"248_CR15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1269\/jrr.44.31","volume":"44","author":"SK Chen","year":"2003","unstructured":"Chen SK, Hsieh WA, Tsai MH, Chen CC, Hong AI, Wei YH, Chang WP (2003) Age-associated decrease of oxidative repair enzymes human 8-oxoguanine DNA glycosylases (OGG1), in human aging. J Radiat Res (Tokyo) 44:31\u201335","journal-title":"J Radiat Res (Tokyo)"},{"key":"248_CR16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0921-8777(01)00096-9","volume":"486","author":"K Janssen","year":"2001","unstructured":"Janssen K, Schlink K, G\u00f6tte W, Hippler B, Kaina B, Oesch F (2001) DNA repair activity of 8-oxoguanine DNA glycosylase 1 (OGG1) in human lymphocytes is not dependent on genetic polymorphism Ser326\/Cys326. Mutat Res 486:207\u2013216","journal-title":"Mutat Res"},{"key":"248_CR17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1158\/1055-9965.EPI-04-0295","volume":"14","author":"AJ Lee","year":"2005","unstructured":"Lee AJ, Hodges NJ, Chipman JK (2005) Interindividual variability in response to sodium dichromate-induced oxidative DNA damage: role of the Ser326Cys polymorphism in the DNA-repair protein of 8-oxo-7, 8-dihydro-2\u2032-deoxyguanosine DNA glycosylase 1. Cancer Epidemiol Biomark Prev 14:497\u2013505","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"248_CR18","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1158\/0008-5472.CAN-08-3943","volume":"69","author":"A Bravard","year":"2009","unstructured":"Bravard A, Vacher M, Moritz E, Vaslin L, Hall J, Epe B, Radicella JP (2009) Oxidation status of human OGG1-S326C polymorphic variant determines cellular DNA repair capacity. Cancer Res 69:3642\u20133649","journal-title":"Cancer Res"},{"key":"248_CR19","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1126\/science.1069424","volume":"296","author":"SB Gabriel","year":"2002","unstructured":"Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D (2002) The structure of haplotype blocks in the human genome. Science 296:2225\u20132229","journal-title":"Science"},{"key":"248_CR20","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1038\/npp.2008.17","volume":"33","author":"E Childs","year":"2008","unstructured":"Childs E, Hohoff C, Deckert J, Xu K, Badner J, de Wit H (2008) Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 33:2791\u20132800","journal-title":"Neuropsychopharmacology"},{"key":"248_CR21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2350-7-79","volume":"7","author":"M Mai","year":"2006","unstructured":"Mai M, Akkad AD, Wieczorek S, Saft C, Andrich J, Kraus PH, Epplen JT, Arning L (2006) No association between polymorphisms in the BDNF gene and age at onset in Huntington disease. BMC Med Genet 7:79","journal-title":"BMC Med Genet"}],"container-title":["neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-010-0248-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10048-010-0248-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-010-0248-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:02:36Z","timestamp":1559116956000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10048-010-0248-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,30]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["248"],"URL":"https:\/\/doi.org\/10.1007\/s10048-010-0248-3","relation":{},"ISSN":["1364-6745","1364-6753"],"issn-type":[{"value":"1364-6745","type":"print"},{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,30]]}}}